Informations:
Erreur:
ID
33807
Description
The Beneficial Effect of Vitamin D Supplement to Peg Interferon Alpha 2a or to Telbivudine Monotherapy in Patients With Chronic Hepatitis B Virus (HBV) Infection; ODM derived from: https://clinicaltrials.gov/show/NCT01083251
Lien
https://clinicaltrials.gov/show/NCT01083251
Mots-clés
Versions (1)
- 28/12/2018 28/12/2018 -
Détendeur de droits
See clinicaltrials.gov
Téléchargé le
28 décembre 2018
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Hepatitis B Virus NCT01083251
Eligibility Hepatitis B Virus NCT01083251
- StudyEvent: Eligibility
Similar models
Eligibility Hepatitis B Virus NCT01083251
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Hepatitis B surface antigen positive Duration
Item
patients were eligible if they had been hbsag positive for at least 6 months,
boolean
C0149709 (UMLS CUI [1,1])
C0449238 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,2])
Hepatitis B e antigen positive | Hepatitis B e antigen negative
Item
patients were hbeag positive or negative,
boolean
C0392390 (UMLS CUI [1])
C0948827 (UMLS CUI [2])
C0948827 (UMLS CUI [2])
Alanine aminotransferase increased
Item
patients had increased serum alt levels between 1 and 10 times the upper limit of normal (uln),
boolean
C0151905 (UMLS CUI [1])
Hepatitis B DNA Measurement
Item
patients had serum hbv-dna levels greater than 1.0 x 10e5 copies/ml (2.0 x 10e4 iuml), and
boolean
C3641250 (UMLS CUI [1])
Signs and Symptoms Biopsy of liver | Consistent with Chronic Hepatitis B
Item
patients had findings on a liver biopsy within the preceding 12 months that were consistent with the presence of chronic hepatitis b.
boolean
C0037088 (UMLS CUI [1,1])
C0193388 (UMLS CUI [1,2])
C0332290 (UMLS CUI [2,1])
C0524909 (UMLS CUI [2,2])
C0193388 (UMLS CUI [1,2])
C0332290 (UMLS CUI [2,1])
C0524909 (UMLS CUI [2,2])
Decompensated liver disease
Item
decompensated liver disease,
boolean
C4075847 (UMLS CUI [1])
Antiviral Therapy
Item
antiviral therapy within 6 months before randomization,
boolean
C0280274 (UMLS CUI [1])
Coinfection Viral | HCV coinfection | Hepatitis Delta Virus Coinfection | HIV coinfection
Item
viral co-infections (hepatitis c virus, hepatitis delta virus, or human immunodeficiency virus), or
boolean
C0275524 (UMLS CUI [1,1])
C0521026 (UMLS CUI [1,2])
C1698259 (UMLS CUI [2])
C0011220 (UMLS CUI [3,1])
C0275524 (UMLS CUI [3,2])
C4062778 (UMLS CUI [4])
C0521026 (UMLS CUI [1,2])
C1698259 (UMLS CUI [2])
C0011220 (UMLS CUI [3,1])
C0275524 (UMLS CUI [3,2])
C4062778 (UMLS CUI [4])
Neutropenia Pre-existing | Thrombocytopenia Pre-existing
Item
pre-existent neutropenia or thrombocytopenia.
boolean
C0027947 (UMLS CUI [1,1])
C2347662 (UMLS CUI [1,2])
C0040034 (UMLS CUI [2,1])
C2347662 (UMLS CUI [2,2])
C2347662 (UMLS CUI [1,2])
C0040034 (UMLS CUI [2,1])
C2347662 (UMLS CUI [2,2])